Active Ingredient: DARIDOREXANT HYDROCHLORIDE
Proprietary Name: QUVIVIQ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214985
Product Number: 002
Approval Date: Apr 7, 2022
Applicant Holder Full Name: IDORSIA PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
